Scrip Asks...What Does 2022 Hold For Biopharma? Part 3: Technology And Science
Genetic Medicines, RNA Technologies, Protein Degraders Among Hot Areas
Many industry leaders expect broad progress in the field of RNA technologies following the rapid and successful roll-out of mRNA vaccines against COVID-19 last year. Genetic medicines of various types, emerging platforms for tackling previously “undruggable” targets and the microbiome were among other areas singled out as areas to watch in 2022.
